Publikationen von J. Bourhis sortiert nach Zeitschrift und Typ
Cancer / Radiothérapie
| , , , , , und , (18F)-FDG PET/CT parameters to predict survival and recurrence in patients with locally advanced cervical cancer treated with chemoradiotherapy (2018), in: Cancer / Radiothérapie, 22:3(229-235) |
[DOI] [URL] |
Clinical Nuclear Medicine
, , , , , und , Metabolic Tumor Volume and Total Lesion Glycolysis in Oropharyngeal Cancer treated with definitive radiotherapy: Which threshold is the best predictor of local control ? (2017), in: Clinical Nuclear Medicine, 42:6(e281–e285)
|
|
Critical Reviews in Oncology/Hematology
, , , , , , , und , Overview of the predictive value of quantitative 18 FDG PET in head and neck cancer treated with chemoradiotherapy (2016), in: Critical Reviews in Oncology/Hematology, 108(40-51)
|
|
European Journal of Cancer
, , , , , , , , , , , , und , A PET-based nomogram for oropharyngeal cancers (2017), in: European Journal of Cancer, 75(222-230)
|
|
European Journal of Nuclear Medicine and Molecular Imaging
, , , , , , , , , , , , und , PET-based predictive survival model after radiotherapy for head and neck cancer (2019), in: European Journal of Nuclear Medicine and Molecular Imaging, 46:3(638-649)
|
[URL] |
Publikationen vom Typ Inproceedings
2017
| , , , , , , und , 18-FDG PET-CT parameters to predict survival and recurrence in cervical cancer patients treated with chemo-radiotherapy, in: European Society for Radiotherapy and Oncology, Vienna, 2017 |
|
| , , , , , , , , und , Nouveaux paramètres métaboliques du FDG-PET/TDM pour prédire la récurrence et la survie des cancers du col utérin traité par radio-chimiothérapie, in: Société Française de radiothérapie Oncologique, 2017 |
|
| , , , , , , , , und , Valeur de la TEP au 18-FDG pour prédire la récidive dans les cancers ORL non oropharyngé traités par radio-chimiothérapie, in: Société Française de radiothérapie Oncologique, 2017 |
|